Quick Links


    Print

The Good Participatory Practice (GPP) Guidelines for Biomedical HIV Prevention Trials

GPP Guidelines, 2nd Edition (2011)

Now available in English, Chinese, French, Khmer, Portuguese and Thai. Other language translations will be available soon.
Download English version here.
點擊這裡下載中文版。
Télécharger la version française ici.
ទាញយកសេចក្ដីរាយការណ៍ជាខ្មែរឯនេះ
Baixar versão em Português aqui.
ดาวน์โหลดเวอร์ชั่นภาษาไทยที่นี่




What are the GPP Guidelines?

The good participatory practice (GPP) guidelines are intended to provide trial funders, sponsors, and implementers with systematic guidance on how to effectively engage with all stakeholders in the design and conduct of biomedical HIV prevention trials.



Guidelines and documents related to GPP
Ethical Considerations in Biomedical HIV Prevention Trials
(WHO/UNAIDS - 2007)

Ethics Issues for Canadian HIV/AIDS Researchers in International Settings (Canadian Association for HIV/AIDS Research - 2008)

Recommendations for Community Involvement in National Institute of Allergy and Infectious Diseases HIV/AIDS Clinical Trials Research (the HIV/AIDS Network Coordination project - 2009)
(English full doc) (Spanish executive summary)

HIV Prevention Trials Network: Ethics Guidance for Research, 10 June 2009

HPTN Ethics Guidance webpage

AVAC: Global Advocacy for HIV Prevention
101 West 23rd Street   ·  New York, NY  
+1 212.796.6423 (main)   ·  avac@avac.org
Copyright 2012, All rights reserved.
Design by Lomangino Studio | Powered by Orchid Suites Orchid ver. 4.7.6.